Berkeley Lights, a biotechnology company specializing in single-cell analysis, laid off approximately 20% of its workforce in early 2024 as part of a restructuring effort following its acquisition by Bruker. The layoffs, which affected around 80 employees, were implemented to streamline operations and integrate the company into Bruker's Cellular Analysis division. This move reflects broader consolidation trends in the life sciences tools industry, where companies are optimizing their structures post-acquisition to enhance focus and reduce redundancies. Berkeley Lights, known for its Beacon platform, continues to operate within Bruker, aiming to advance its technology for therapeutic discovery and development.
